Quadria Capital a leading Asian healthcare focused private equity investor has made an investment in HealthCare Global Enterprises’ (HCG) Strand Life Sciences (Strand). The investment follows the previously announced combination of Triesta Sciences, a unit of HCG, and Strand, creating India’s leading specialized diagnostics player. The investment by Quadria will fund the strategic expansion of Strand and the build out of a unique integrated platform dedicated to next generation precision medicine.
HealthCare Global Enterprises is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.
